Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma
Clinical trial NCT02970981 · COMPLETED
Trial details
- NCT number
- NCT02970981
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-29
- Primary completion
- 2018-11-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.